Article

A simple model of pathogen-immune dynamics including specific and non-specific immunity

Department of Mathematics, University of Trento, Via Sommarive 14, Trento 38050, Italy.
Mathematical Biosciences (Impact Factor: 1.49). 06/2008; 214(1-2):73-80. DOI: 10.1016/j.mbs.2008.04.004
Source: PubMed

ABSTRACT We present and analyze a model for the dynamics of the interactions between a pathogen and its host's immune response. The model consists of two differential equations, one for pathogen load, the other one for an index of specific immunity. Differently from other simple models in the literature, this model exhibits, according to the hosts' or pathogen's parameter values, or to the initial infection size, a rich repertoire of behaviours: immediate clearing of the pathogen through aspecific immune response; or acute infection followed by clearing of the pathogen through specific immune response; or uncontrolled infections; or acute infection followed by convergence to a stable state of chronic infection; or periodic solutions with intermittent acute infections. The model can also mimic some features of immune response after vaccination. This model could be a basis on which to build epidemic models including immunological features.

Download full-text

Full-text

Available from: Andrea Pugliese, Aug 23, 2015
2 Followers
 · 
202 Views
  • Source
    • "Note that recovery is not explicitly modelled in this system; however, when an individual reaches a B level close to B ∞ , it is effectively immune to further infections and its pathogen load is effectively 0. Other simple models for within-host pathogen–immune interactions have been considered [24] [28] [33] with potentially different behaviours that may be realistic in many cases. For the purpose of this analysis, system (1) describes adequately the dynamics of an acute infection that is eventually cleared by the immune system. "
    [Show abstract] [Hide abstract]
    ABSTRACT: I examine here the effects of host heterogeneity in the growth of immune response on the evolution and co-evolution of virulence. The analysis is based on an extension of the 'nested model' by Gilchrist and Sasaki [Modeling host-parasite coevolution, J. Theor. Biol. 218 (2002), pp. 289-308]; the criteria for host and parasite evolution, in the paradigm of adaptive dynamics, for that model are derived in generality. Host heterogeneity is assumed to be fixed at birth according to a lognormal distribution or to the presence of two discrete types. In both cases, it is found that host heterogeneity determines a dramatic decrease in pathogen virulence, since pathogens will tune to the 'weakest' hosts. Finally we clarify how contrasting results present in the literature are due to different modelling assumptions.
    Journal of Biological Dynamics 03/2011; 5(2):104-19. DOI:10.1080/17513758.2010.519404 · 1.03 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: An impulsive model of augmentative biological control consisting of a general continuous predator-prey model in ordinary differential equations, i.e. a meta-model, augmented by a discrete part describing periodic introductions of predators is considered. The existence of an invariant periodic solution that corresponds to prey eradication is shown and a condition ensuring its global asymptotic stability is given. An optimisation problem related to the preemptive use of augmentative biological control is then considered. It is assumed that the per time unit budget of biological control (i.e. the number of predators to be released) is fixed and the best deployment of this budget is sought in terms of release frequency. The cost function to be minimised is the time needed to reduce an unforeseen prey (pest) invasion occurring at a worst time instant under some harmless level. The analysis shows that the optimisation problem admits a countable infinite number of solutions. An argumentation considering the required robustness of the optimisation result with respect to the invasive prey population level and to the model parameters is then conducted. It is shown that the cost function is decreasing in the predator release frequency so that the best deployment of the biocontrol agents is to carry out as frequent introductions as possible.
    Mathematical biosciences 08/2009; 221(2):91-100. DOI:10.1016/j.mbs.2009.07.002 · 1.49 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Bacterial infections occur when the natural host defenses are overwhelmed by invading bacteria. The main component of the host defense is impaired when neutrophil count or function is too low, putting the host at great risk of developing an acute infection. In people with intact immune systems, neutrophil count increases during bacterial infection. However, there are two important clinical cases in which they remain constant: a) in patients with neutropenic-associated conditions, such as those undergoing chemotherapy at the nadir (the minimum clinically observable neutrophil level); b) in ex vivo examination of the patient's neutrophil bactericidal activity. Here we study bacterial population dynamics under fixed neutrophil levels by mathematical modelling. We show that under reasonable biological assumptions, there are only two possible scenarios: 1) Bacterial behavior is monostable: it always converges to a stable equilibrium of bacterial concentration which only depends, in a gradual manner, on the neutrophil level (and not on the initial bacterial level). We call such a behavior type I dynamics. 2) The bacterial dynamics is bistable for some range of neutrophil levels. We call such a behavior type II dynamics. In the bistable case (type II), one equilibrium corresponds to a healthy state whereas the other corresponds to a fulminant bacterial infection. We demonstrate that published data of in vitro Staphylococcus epidermidis bactericidal experiments are inconsistent with both the type I dynamics and the commonly used linear model and are consistent with type II dynamics. We argue that type II dynamics is a plausible mechanism for the development of a fulminant infection.
    PLoS ONE 05/2010; 5(5):e10010. DOI:10.1371/journal.pone.0010010 · 3.53 Impact Factor
Show more